Description
Indication & Scope
Bojianing contains bemiltenase alfa, a recombinant coagulation factor X (FX) activator for the treatment of bleeding episodes in adult patients with congenital hemophilia A or B.
- Mechanism: Activates coagulation factor X (FX) to promote coagulation and help control bleeding.
- Drug class: Recombinant coagulation factor X (FX) activator.
- Clinical use: Treatment of bleeding episodes in adult patients with congenital hemophilia A or B.
| Generic Name | Bemiltenase alfa |
| Brand Name | Bojianing® |
| Ingredient | Each vial contains 5 U (0.15 μg) bemiltenase alfa. |
| Dosage Form | Injection |
| Package | Refer to the approved package labeling |
| Conditions Treated | Treatment of bleeding episodes in adult patients with congenital hemophilia A or B. |
| Taboos | Hypersensitivity to bemiltenase alfa or any component of the product. |
| Place of origin | China |
| Prescription type | Prescription Drug (Rx) |
| Storage Conditions | Refer to the approved package labeling |
| Manufacturer | Jiangsu BioJeTay Biotechnology Co., Ltd. |
| Registration Authority | National Medical Products Administration (NMPA), China |
| Approval number | S20260040 |
| Date of Revision | 2026 |
| Shelf Life | Refer to the approved package labeling |
How to use ?
Recommended Dose: Administer according to the approved dosing regimen and clinical protocol for the treatment of bleeding episodes in adult patients with congenital hemophilia A or B.
Time: Administer according to the approved treatment schedule.
Instructions for use: Administer by intravenous injection according to the approved prescribing information. Use only under the supervision of healthcare professionals experienced in the management of hemophilia.
Interaction: No clinically significant drug interactions have been identified.
Side effects: Refer to the approved package labeling.
Important Notice
Gumokimab is a humanized monoclonal antibody that specifically binds to IL-17A. It competitively blocks the IL-17/IL-17R signaling cascade, thereby suppressing the initiation and progression of autoimmune inflammatory responses associated with plaque psoriasis and spondyloarthritis.
Packaging & Shipping
Packaging
Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.
Shipping Methods
Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.
Export Support
Certificate of Analysis
GMP Certificate
Commercial Invoice
Packing List & CPP
Cold Chain Logistics
Customs Documentation
Scientific and regulatory sources
FAQ
What is Bojianing (Bemiltenase alfa)?
Bojianing is a recombinant coagulation factor X (FX) activator developed for the treatment of bleeding episodes in adult patients with congenital hemophilia A or B.
How does Bojianing work？
It activates coagulation factor X (FX) to promote the coagulation process and help control bleeding.
What is Bojianing used for?
It is used for the treatment of bleeding episodes in adult patients with congenital hemophilia A or B.
What are the advantages of Bemiltenase alfa?
Bemiltenase alfa provides a novel bypass approach for hemophilia A or B patients requiring bleeding control.
Bojianing® Bemiltenase alfa | Hemophilia A/B with Inhibitors | DengYueRX
INN: Bemiltenase alfa
Indications: Treatment of bleeding episodes in adult patients with congenital hemophilia A or B, including patients with inhibitors.
Dosage Form: Injection
Strength: 5U(0.15 μg)/vial
